Literature DB >> 27135551

Anomeric Effects in Sulfamides.

Eric Hansen1, Elaine Limé2, Per-Ola Norrby2, Olaf Wiest1,3.   

Abstract

Sulfamides, together with their simpler sulfonamide analogs, are common functional groups in a significant number of biologically active compounds. This is partly due to their unique electronic structure and conformational behavior, which mimics the tetrahedral intermediate involved in many proteases, esterases, and related enzymes. Here, the origin of these unique structural elements are analyzed in the context of a coupled, double anomeric effect using DFT calculations, including conformational scans, and NBO analysis. It is shown that these coupled interactions can be implicitly parametrized in MM3* type force fields using the quantum-guided molecular mechanics (Q2MM) method, yielding accurate force field parameters for molecular mechanics studies of sulfamides and sulfonamides.

Entities:  

Year:  2016        PMID: 27135551      PMCID: PMC5542809          DOI: 10.1021/acs.jpca.6b02757

Source DB:  PubMed          Journal:  J Phys Chem A        ISSN: 1089-5639            Impact factor:   2.781


  13 in total

1.  Theoretical Studies of the Sulfenate-Sulfoxide Rearrangement.

Authors:  Jérôme Amaudrut; Daniel J. Pasto; Olaf Wiest
Journal:  J Org Chem       Date:  1998-08-21       Impact factor: 4.354

2.  Prediction of enantioselectivity in rhodium catalyzed hydrogenations.

Authors:  Patrick J Donoghue; Paul Helquist; Per-Ola Norrby; Olaf Wiest
Journal:  J Am Chem Soc       Date:  2009-01-21       Impact factor: 15.419

3.  Improving the Q2MM method for transition state force field modeling.

Authors:  Elaine Limé; Per-Ola Norrby
Journal:  J Comput Chem       Date:  2014-11-27       Impact factor: 3.376

4.  Domagk and the development of the sulphonamides.

Authors:  H Otten
Journal:  J Antimicrob Chemother       Date:  1986-06       Impact factor: 5.790

5.  Extension of the CHARMM General Force Field to sulfonyl-containing compounds and its utility in biomolecular simulations.

Authors:  Wenbo Yu; Xibing He; Kenno Vanommeslaeghe; Alexander D MacKerell
Journal:  J Comput Chem       Date:  2012-07-23       Impact factor: 3.376

Review 6.  Carbonic anhydrases as targets for medicinal chemistry.

Authors:  Claudiu T Supuran; Andrea Scozzafava
Journal:  Bioorg Med Chem       Date:  2007-04-19       Impact factor: 3.641

7.  Development of a Q2MM Force Field for the Asymmetric Rhodium Catalyzed Hydrogenation of Enamides.

Authors:  Patrick J Donoghue; Paul Helquist; Per-Ola Norrby; Olaf Wiest
Journal:  J Chem Theory Comput       Date:  2008-08       Impact factor: 6.006

8.  Molecular structure and conformations of para-methylbenzene sulfonamide and ortho-methylbenzene sulfonamide: gas electron diffraction and quantum chemical calculations study.

Authors:  Vjacheslav M Petrov; Georgiy V Girichev; Heinz Oberhammer; Valentina N Petrova; Nina I Giricheva; Anna V Bardina; Sergey N Ivanov
Journal:  J Phys Chem A       Date:  2008-02-27       Impact factor: 2.781

9.  Stereoselectivity in Asymmetric Catalysis: The Case of Ruthenium-Catalyzed Ketone Hydrogenation.

Authors:  Elaine Limé; Michelle D Lundholm; Aaron Forbes; Olaf Wiest; Paul Helquist; Per-Ola Norrby
Journal:  J Chem Theory Comput       Date:  2014-06-10       Impact factor: 6.006

10.  Prediction of Stereochemistry using Q2MM.

Authors:  Eric Hansen; Anthony R Rosales; Brandon Tutkowski; Per-Ola Norrby; Olaf Wiest
Journal:  Acc Chem Res       Date:  2016-04-11       Impact factor: 22.384

View more
  2 in total

1.  Predictions of Ligand Selectivity from Absolute Binding Free Energy Calculations.

Authors:  Matteo Aldeghi; Alexander Heifetz; Michael J Bodkin; Stefan Knapp; Philip C Biggin
Journal:  J Am Chem Soc       Date:  2017-01-09       Impact factor: 15.419

2.  Experiment stands corrected: accurate prediction of the aqueous pK a values of sulfonamide drugs using equilibrium bond lengths.

Authors:  Beth A Caine; Maddalena Bronzato; Paul L A Popelier
Journal:  Chem Sci       Date:  2019-05-29       Impact factor: 9.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.